Crossref
Clinical Efficacy of Tenofovir and Entecavir as Antiviral Agents in Hepatitis B Virus-Associated Transarterial Chemoembolization
Journal of Clinical Personalized Medicine · 2024
DOI: 10.12677/jcpm.2024.31003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Personalized Medicine, 2024. Verfasst von 鑫杰 郭. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
郭, 鑫. (2024). Clinical Efficacy of Tenofovir and Entecavir as Antiviral Agents in Hepatitis B Virus-Associated Transarterial Chemoembolization. Journal of Clinical Personalized Medicine. https://doi.org/10.12677/jcpm.2024.31003
Vancouver
郭 鑫. Clinical Efficacy of Tenofovir and Entecavir as Antiviral Agents in Hepatitis B Virus-Associated Transarterial Chemoembolization. Journal of Clinical Personalized Medicine. 2024. doi:10.12677/jcpm.2024.31003
BibTeX
@article{2024,
author = {郭, 鑫杰},
title = {Clinical Efficacy of Tenofovir and Entecavir as Antiviral Agents in Hepatitis B Virus-Associated Transarterial Chemoembolization},
journal = {Journal of Clinical Personalized Medicine},
year = {2024},
doi = {10.12677/jcpm.2024.31003}
}
EUVIMED